Ad
related to: drugmaker
Search results
Merck nears $1.3 bln takeover of Eyebiotech- WSJ
Investing.com via Yahoo Finance· 1 day agoInvesting.com-- Merck&Company Inc (NYSE:MRK) is close to entering a $1.3 billion deal to buy Eyebiotech, granting the pharmaceutical giant entry into the rapidly growing eyecare market, the Wall Street Journal reported on Tuesday.
Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster | The Motley Fool
The Motley Fool· 7 days agoThe pharmaceutical company has made quite a bit of noise over the past few years thanks to notable...
Eli Lilly to spend $5.3 billion to boost Zepbound, Mounjaro manufacturing
Market Watch· 5 days agoThe Indianapolis drugmaker said a new $5.3 billion commitment will bring its total spending on the...
US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
Reuters via AOL· 5 days agoNovo is aiming to be the first to hit the market with a weekly insulin product, offering an...
Emcure, HDT settle legal fight over COVID vaccine technology
Reuters via AOL· 5 days agoIndian generic drugmaker Emcure Pharmaceuticals and U.S. vaccine developer HDT Bio have settled allegations that Emcure stole HDT trade secrets during their joint work on ...
Feds plan for smoother access to RSV infant shot
Politico· 9 hours agoThe campaign, “How PBMs Work,” aims to counter drugmakers’ attacks on PBMs, blaming them for driving up the cost of medicines. The videos — short vignettes and longer-form ...
High drug prices? Senators blame Big Pharma for abuse of the drug patent system
BenefitsPRO· 9 hours agoJohn Cornyn, R-Texas, said. "But at the same time, I'm angry when I look at the abuse of the patent...
This 5-Star Stock With a Dividend Yield That Tops 4% Is a Buy
Morningstar· 12 hours agoGilead Sciences GILD has relied on its HIV and hepatitis C portfolio to drive profit margins. Gilead...
J&J's drug eases depression and insomnia symptoms in late-stage study
Reuters· 9 hours ago, opens new tab experimental drug helped reduce symptoms of depression as well as insomnia in...
This Unpopular Dividend Stock Is a Buy
Motley Fool via Yahoo Finance· 7 days agoImage source: Getty Images. Bristol Myers Squibb (NYSE: BMY), or BMS for short, is a prime example. The drugmaker's shares are down by over 17% year to...
